David D. Chang - May 16, 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: President and CEO, Director
Signature: /s/Earl Douglas, Attorney-in-Fact
Stock symbol: ALLO
Transactions as of: May 16, 2024
Transactions value $: $1,000,001
Form type: 4
Date filed: 5/20/2024, 06:01 PM
Previous filing: Mar 18, 2024
Next filing: Jan 28, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Award	$1M	+345K	+7.72%	$2.90	4.81M	May 16, 2024	Direct	F1
holding	ALLO	Common Stock						1.2M	May 16, 2024	See footnote	F2
holding	ALLO	Common Stock						856K	May 16, 2024	See footnote	F3
holding	ALLO	Common Stock						856K	May 16, 2024	See footnote	F4

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.
F2	Securities held in the name of the Chang 2006 Family Trust
F3	Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
F4	Securities held in the name of the RTC 2019 Trust dated October 1, 2019.